TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Vaccines & Vaccination Market Research Report 2023

Global Vaccines & Vaccination Market Research Report 2023

  • Category:Life Sciences
  • Published on : 03 January 2023
  • Pages :87
  • Formats:
  • Report Code:SMR-7527553

Market Analysis and Insights: Global Vaccines & Vaccination Market

The global Vaccines & Vaccination market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vaccines & Vaccination market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vaccines & Vaccination market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vaccines & Vaccination market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vaccines & Vaccination market.

Global Vaccines & Vaccination Scope and Market Size

Vaccines & Vaccination market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Vaccines & Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.
Segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Segment by Application
Baby Vaccine
Adult Special Vaccine
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Vaccines & Vaccination product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Vaccines & Vaccination, with price, sales, revenue, and global market share of Vaccines & Vaccination from 2019 to 2022.

Chapter 3, the Vaccines & Vaccination competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Vaccines & Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Vaccines & Vaccination market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccines & Vaccination.

Chapter 13, 14, and 15, to describe Vaccines & Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Vaccines & Vaccination Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Subunit vaccines
1.2.3 Live attenuated vaccines
1.2.4 Conjugate vaccines
1.2.5 Inactivated vaccines
1.2.6 Recombinant vector vaccines
1.2.7 Toxoid vaccines
1.2.8 Synthetic vaccines
1.2.9 Dendritic cell vaccines
1.3 Market by Application
1.3.1 Global Vaccines & Vaccination Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Baby Vaccine
1.3.3 Adult Special Vaccine
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2018-2030)
2.2 Vaccines & Vaccination Growth Trends by Region
2.2.1 Vaccines & Vaccination Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Vaccines & Vaccination Historic Market Size by Region (2018-2023)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Region (2023-2030)
2.3 Vaccines & Vaccination Market Dynamics
2.3.1 Vaccines & Vaccination Industry Trends
2.3.2 Vaccines & Vaccination Market Drivers
2.3.3 Vaccines & Vaccination Market Challenges
2.3.4 Vaccines & Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Revenue
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2018-2023)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2018-2023)
3.2 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccines & Vaccination Revenue
3.4 Global Vaccines & Vaccination Market Concentration Ratio
3.4.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2022
3.5 Vaccines & Vaccination Key Players Head office and Area Served
3.6 Key Players Vaccines & Vaccination Product Solution and Service
3.7 Date of Enter into Vaccines & Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccines & Vaccination Breakdown Data by Type
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2018-2023)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2023-2030)
5 Vaccines & Vaccination Breakdown Data by Application
5.1 Global Vaccines & Vaccination Historic Market Size by Application (2018-2023)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2018-2030)
6.2 North America Vaccines & Vaccination Market Size by Country (2018-2023)
6.3 North America Vaccines & Vaccination Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2018-2030)
7.2 Europe Vaccines & Vaccination Market Size by Country (2018-2023)
7.3 Europe Vaccines & Vaccination Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size (2018-2030)
8.2 Asia-Pacific Vaccines & Vaccination Market Size by Country (2018-2023)
8.3 Asia-Pacific Vaccines & Vaccination Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size (2018-2030)
9.2 Latin America Vaccines & Vaccination Market Size by Country (2018-2023)
9.3 Latin America Vaccines & Vaccination Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size (2018-2030)
10.2 Middle East & Africa Vaccines & Vaccination Market Size by Country (2018-2023)
10.3 Middle East & Africa Vaccines & Vaccination Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccines & Vaccination Introduction
11.1.4 Abbott Revenue in Vaccines & Vaccination Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccines & Vaccination Introduction
11.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Bavarian Nordic
11.3.1 Bavarian Nordic Company Detail
11.3.2 Bavarian Nordic Business Overview
11.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
11.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2018-2023)
11.3.5 Bavarian Nordic Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Vaccines & Vaccination Introduction
11.4.4 Novartis Revenue in Vaccines & Vaccination Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Bharat Biotech
11.5.1 Bharat Biotech Company Detail
11.5.2 Bharat Biotech Business Overview
11.5.3 Bharat Biotech Vaccines & Vaccination Introduction
11.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2018-2023)
11.5.5 Bharat Biotech Recent Development
11.6 Bio-Med
11.6.1 Bio-Med Company Detail
11.6.2 Bio-Med Business Overview
11.6.3 Bio-Med Vaccines & Vaccination Introduction
11.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2018-2023)
11.6.5 Bio-Med Recent Development
11.7 CSL
11.7.1 CSL Company Detail
11.7.2 CSL Business Overview
11.7.3 CSL Vaccines & Vaccination Introduction
11.7.4 CSL Revenue in Vaccines & Vaccination Business (2018-2023)
11.7.5 CSL Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Company Detail
11.8.2 Emergent BioSolutions Business Overview
11.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
11.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2018-2023)
11.8.5 Emergent BioSolutions Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Vaccines & Vaccination Introduction
11.9.4 GSK Revenue in Vaccines & Vaccination Business (2018-2023)
11.9.5 GSK Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
11.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2018-2023)
11.10.5 Johnson & Johnson Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Vaccines & Vaccination Introduction
11.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2018-2023)
11.11.5 Pfizer Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Vaccines & Vaccination Introduction
11.12.4 Merck Revenue in Vaccines & Vaccination Business (2018-2023)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Vaccines & Vaccination Introduction
11.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2018-2023)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Subunit vaccines
Table 3. Key Players of Live attenuated vaccines
Table 4. Key Players of Conjugate vaccines
Table 5. Key Players of Inactivated vaccines
Table 6. Key Players of Recombinant vector vaccines
Table 7. Key Players of Toxoid vaccines
Table 8. Key Players of Synthetic vaccines
Table 9. Key Players of Dendritic cell vaccines
Table 10. Global Vaccines & Vaccination Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 11. Global Vaccines & Vaccination Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 12. Global Vaccines & Vaccination Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Vaccines & Vaccination Market Share by Region (2018-2023)
Table 14. Global Vaccines & Vaccination Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 15. Global Vaccines & Vaccination Market Share by Region (2023-2030)
Table 16. Vaccines & Vaccination Market Trends
Table 17. Vaccines & Vaccination Market Drivers
Table 18. Vaccines & Vaccination Market Challenges
Table 19. Vaccines & Vaccination Market Restraints
Table 20. Global Vaccines & Vaccination Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Vaccines & Vaccination Market Share by Players (2018-2023)
Table 22. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2022)
Table 23. Ranking of Global Top Vaccines & Vaccination Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Vaccines & Vaccination Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Vaccines & Vaccination Product Solution and Service
Table 27. Date of Enter into Vaccines & Vaccination Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Vaccines & Vaccination Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Vaccines & Vaccination Revenue Market Share by Type (2018-2023)
Table 31. Global Vaccines & Vaccination Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 32. Global Vaccines & Vaccination Revenue Market Share by Type (2023-2030)
Table 33. Global Vaccines & Vaccination Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Vaccines & Vaccination Revenue Market Share by Application (2018-2023)
Table 35. Global Vaccines & Vaccination Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 36. Global Vaccines & Vaccination Revenue Market Share by Application (2023-2030)
Table 37. North America Vaccines & Vaccination Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Vaccines & Vaccination Market Size by Country (2023-2030) & (US$ Million)
Table 39. Europe Vaccines & Vaccination Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Vaccines & Vaccination Market Size by Country (2023-2030) & (US$ Million)
Table 41. Asia-Pacific Vaccines & Vaccination Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Vaccines & Vaccination Market Size by Region (2023-2030) & (US$ Million)
Table 43. Latin America Vaccines & Vaccination Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Vaccines & Vaccination Market Size by Country (2023-2030) & (US$ Million)
Table 45. Middle East & Africa Vaccines & Vaccination Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Vaccines & Vaccination Market Size by Country (2023-2030) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Vaccines & Vaccination Product
Table 50. Abbott Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca Vaccines & Vaccination Product
Table 55. AstraZeneca Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Bavarian Nordic Company Detail
Table 58. Bavarian Nordic Business Overview
Table 59. Bavarian Nordic Vaccines & Vaccination Product
Table 60. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 61. Bavarian Nordic Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Vaccines & Vaccination Product
Table 65. Novartis Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Bharat Biotech Company Detail
Table 68. Bharat Biotech Business Overview
Table 69. Bharat Biotech Vaccines & Vaccination Product
Table 70. Bharat Biotech Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 71. Bharat Biotech Recent Development
Table 72. Bio-Med Company Detail
Table 73. Bio-Med Business Overview
Table 74. Bio-Med Vaccines & Vaccination Product
Table 75. Bio-Med Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 76. Bio-Med Recent Development
Table 77. CSL Company Detail
Table 78. CSL Business Overview
Table 79. CSL Vaccines & Vaccination Product
Table 80. CSL Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 81. CSL Recent Development
Table 82. Emergent BioSolutions Company Detail
Table 83. Emergent BioSolutions Business Overview
Table 84. Emergent BioSolutions Vaccines & Vaccination Product
Table 85. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 86. Emergent BioSolutions Recent Development
Table 87. GSK Company Detail
Table 88. GSK Business Overview
Table 89. GSK Vaccines & Vaccination Product
Table 90. GSK Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 91. GSK Recent Development
Table 92. Johnson & Johnson Company Detail
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Vaccines & Vaccination Product
Table 95. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Pfizer Company Detail
Table 98. Pfizer Business Overview
Table 99. Pfizer Vaccines & VaccinationProduct
Table 100. Pfizer Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Merck Company Detail
Table 103. Merck Business Overview
Table 104. Merck Vaccines & VaccinationProduct
Table 105. Merck Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Sanofi Company Detail
Table 108. Sanofi Business Overview
Table 109. Sanofi Vaccines & VaccinationProduct
Table 110. Sanofi Revenue in Vaccines & Vaccination Business (2018-2023) & (US$ Million)
Table 111. Sanofi Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccines & Vaccination Market Share by Type: 2022 VS 2030
Figure 2. Subunit vaccines Features
Figure 3. Live attenuated vaccines Features
Figure 4. Conjugate vaccines Features
Figure 5. Inactivated vaccines Features
Figure 6. Recombinant vector vaccines Features
Figure 7. Toxoid vaccines Features
Figure 8. Synthetic vaccines Features
Figure 9. Dendritic cell vaccines Features
Figure 10. Global Vaccines & Vaccination Market Share by Application in 2022 & 2030
Figure 11. Baby Vaccine Case Studies
Figure 12. Adult Special Vaccine Case Studies
Figure 13. Other Case Studies
Figure 14. Vaccines & Vaccination Report Years Considered
Figure 15. Global Vaccines & Vaccination Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 16. Global Vaccines & Vaccination Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 17. Global Vaccines & Vaccination Market Share by Region: 2022 VS 2030
Figure 18. Global Vaccines & Vaccination Market Share by Players in 2022
Figure 19. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2022
Figure 21. North America Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. North America Vaccines & Vaccination Market Share by Country (2018-2030)
Figure 23. United States Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Canada Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Europe Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. Europe Vaccines & Vaccination Market Share by Country (2018-2030)
Figure 27. Germany Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. France Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. U.K. Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Italy Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Russia Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Nordic Countries Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Asia-Pacific Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Asia-Pacific Vaccines & Vaccination Market Share by Region (2018-2030)
Figure 35. China Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. Japan Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. South Korea Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. India Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Australia Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Latin America Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Latin America Vaccines & Vaccination Market Share by Country (2018-2030)
Figure 43. Mexico Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 44. Brazil Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 45. Middle East & Africa Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 46. Middle East & Africa Vaccines & Vaccination Market Share by Country (2018-2030)
Figure 47. Turkey Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 48. Saudi Arabia Vaccines & Vaccination Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 51. Bavarian Nordic Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 53. Bharat Biotech Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 54. Bio-Med Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 55. CSL Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 56. Emergent BioSolutions Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 57. GSK Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 58. Johnson & Johnson Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 60. Merck Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Vaccines & Vaccination Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount